Vincent Dagommer Email & Phone Number

Paris, FR

For 20 years, Truffle Capital has been creating and financing to success radical and disruptive innovations in two fields of expertise, Life Sciences and Information Technologies. These creations revolutionize their sectors and will become the tomorrow’s leaders.BioMedTechTruffle Capital works closely with the world's best 50 universities to select and.

Villepinte, Seine-Saint-Denis, FR

Kick-off and deployment of a major global transformation program to enhance the performance of a multinational corporation with sales in excess of 700M€ and a global presence (40% in Europe, 60% in USA, Asia, Latam and ROW)

Villepinte, Seine-Saint-Denis, FR

Integration of Accurate Medical Therapeutics, an inovative Israeli interventional radiology startup acquired by Guerbet in February 2018. Acquisition of a microspheres technology from Occlugel in April 2018 and sponsor of the technology's development into commercial products at Guerbet.Divestment of Guerbet's pharmaceuticals and medical devices.

Villepinte, Seine-Saint-Denis, FR

Management of the French commercial affiliate of Guerbet. Delivered sales and profits ahead of the budget despite the entry in 2017 of a generic against our top margin contributor product.

Villepinte, Seine-Saint-Denis, FR

Lead the day 1 readiness at closing and successful integration of the Contrast Media and Delivery Systems activity of Mallinckrodt (CMDS - 980 employees and approx $400M sales) and Guerbet, following the $270M agreement entered into end of July 2015 for the acquisition of CMDS by Guerbet.

Villepinte, Seine-Saint-Denis, FR

Management of the Belgian affiliate of Guerbet covering Belgium and Luxembourg. Outsourcing of warehousing and relocation of the head office, launch of a new CT injector, management of public tenders, preparation and submission of reimbursement and price dossiers

Villepinte, Seine-Saint-Denis, FR

Chairman of the Audit Committee from July 2013 until March 2014Member of the Strategic Committee and of the Audit Committee from May 2010 to March 2014

Basel, Baselstadt, CH

Responsible for divestment of non-strategic brands in the Novartis OTC portfolio, from opportunity identification to transaction signature. Completed 4 transactions in 2012 and 2013, delivering financial proceeds in excess of €60Mio, including a complex deal involving the transfer of the entire medical field force of Novartis OTC France (50 headcounts).

Basel, Baselstadt, CH

Responsible for Financial Management of Novartis OTC Europe Cost of Goods and Logistics Costs ($440Mio costs), coordination of planning and monitoring over 7 operating units covering 25 countries. Financial management of a manufacturing plant shutdown in the UK in 2008Financial Management of Novartis Nyon Contract Manufacturing operations ($350Mio.

Basel, Baselstadt, CH

. Financial support to Contract Manufacturing operations and manufacturing aspects of licensing deals for Novartis Over-The-Counter (OTC)products. Financial review of OTC manufacturing investments. Financial responsibility for OTC production transfer decisions and other ad hoc analyses. Performance tracking of OTC Product Supply and Manufacturing

Basel, Baselstadt, CH

. Performance tracking of Novartis Consumer Health Division ($7'500MM Sales, $1'100MM EBIT). Preparation of monthly and budget reportings to the BOD and Executive Committee of Novartis. Review of Major Investments and Deals. Project leader for a pan-european restructuring projects of Shared Services after the divestiture of the Ovomaltine brand

Basel, Baselstadt, CH

. Performance tracking of the Over-The-Counter business unit of Novartis Consumer Health (Sales $1'500MM, EBIT $240MM). Review of OTC Deals and Major investments

Leverkusen, North Rhine-Westphalia, DE

. Sales Performance monitoring. Cost Center tracking of the Sales Department (350 employees + 140 headcount in contract sales forces). Financial responsibility for management of contract Sales Forces. Implementation of a Corporate Credit Card replacing cash advances to employees for the payment of professional expenses (500 users).. Finance representative.

Châtillon, Île-de-France, FR

Controller in the Group Controlling Department 1994-1996. Preparation of reportings for the BOD and Executive Committee, contributor to the Annual Report writing.. Group Performance monitoring with focus on the Industry branch and Tresury activity ($3'000MM treasury managed)Project Manager - Technical Direction of the Reprocessing Branch - 1997..

Villepinte, Seine-Saint-Denis, FR

Assignement as part of the French National Service11 months responsible for General Services, interface to advocacy firms and management of freight expenses (negotiation of prices in an hyper-inflationary environment, request for quotes and cost-based allocation of various types and destinations of freight to several vendors)6 months: support to the Sales.

Indianapolis, Indiana, US

12 months sandwich-year during the course of the ESCP program.Junior Controller for the Animal Health business unit. Performance monitoring and reporting, ad hoc analysesImplementation of an IT tracking tool for marketing expense commitments, interface beween users (Marketing department) and the IT developers.

Master Of Business Administration (Mba), Management. Major In Marketing, Minor In Finance

Baccalauréat